ABP
ABP
NASDAQ · Biotechnology

Abpro Holdings Inc

$1.50
+0.00 (+0.00%)
As of Feb 8, 2:33 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 1.55M 1.36M 1.68M
Net Income 56.6K 59.8K 87.7K
EPS
Profit Margin 3.7% 4.4% 5.2%
Rev Growth -6.9% +10.8% +11.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 970.3K 829.5K 910.4K
Total Equity 1.39M 1.41M 1.26M
D/E Ratio 0.70 0.59 0.72
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA 150.2K 130.3K 163.2K
Free Cash Flow 63.5K 61.7K 63.4K